Investment Case

Differential business model

  • Acquire, prepare, commercialise

Global Commerical Deal

  • Global commercial deal for the launch of unique skincare brand Skin + CELL announced Dec 2023, expected to generate significant revenues and profitability in 2024 and beyond

Strategic partners (second commercial deal signed)

  • Proves business model to commercialise products at earliest stage

Multi-product portfolio

  • Minimises risk of single product development


  • Driving shareholder value